JDA

SES Reports Fourth Quarter 2022 Financial Results

Retrieved on: 
Tuesday, March 14, 2023
Automotive Manufacturing, Alternative Energy, Green Technology, Energy, Manufacturing, Alternative Vehicles, Fuels, Technology, Recycling, EV, Electric Vehicles, Other Transport, Environment, Artificial Intelligence, Transport, Automotive, Software, Logistics, Supply Chain Management, EVS, Letter, SES, NYSE, JDA, Cryptocurrency

SES AI Corporation (NYSE: SES), headquartered in Boston, a global leader in the development and manufacturing of high-performance lithium-metal (Li-Metal) rechargeable batteries for electric vehicles (EVs) and other applications, today announced its business and financial results for the fourth quarter of 2022, which ended December 31.

Key Points: 
  • SES AI Corporation (NYSE: SES), headquartered in Boston, a global leader in the development and manufacturing of high-performance lithium-metal (Li-Metal) rechargeable batteries for electric vehicles (EVs) and other applications, today announced its business and financial results for the fourth quarter of 2022, which ended December 31.
  • The company posted a Letter to Our Shareholders on its Investor Relations website from Founder and CEO Dr. Qichao Hu and Chief Financial Officer, Jing Nealis, that provides a business update and details its fourth-quarter financial results.
  • “In 2021, SES was the first Li-Metal battery company to establish an automotive A-sample joint development agreement (JDA) and, in 2022, we laid the groundwork for transitioning to B-samples,” said Founder and CEO Qichao Hu.
  • The conference call can also be accessed live over the phone by dialing the following numbers:

H2U Technologies and Tokyo Gas Enter Joint Agreement to Develop Low-Cost Electrolyzers

Retrieved on: 
Thursday, March 9, 2023
Proton, Membrane, Electrolysis, Insurance, Platinum group, Electrocatalyst, Intelligence, JDA, Hydrogen, Proton-exchange membrane, Machine learning, CDE, PEM, Policy, Iridium, Wind, Tokyo, Tokyo Gas, PGM, Palladium

CHATSWORTH, Calif. , March 9, 2023 /PRNewswire/ -- H2U Technologies and Tokyo Gas Co., Ltd. have partnered under a multi-year Joint Development Agreement (JDA) to discover novel catalysts and develop techniques to apply those catalysts onto membranes. The companies will leverage H2U's proprietary Catalyst Discovery Engin™e (CDE™) to reduce the cost of Proton Exchange Membrane (PEM) electrolyzers.

Key Points: 
  • CHATSWORTH, Calif. , March 9, 2023 /PRNewswire/ -- H2U Technologies and Tokyo Gas Co., Ltd. have partnered under a multi-year Joint Development Agreement (JDA) to discover novel catalysts and develop techniques to apply those catalysts onto membranes.
  • By collaborating with H2U and utilizing the CDE, Tokyo Gas aims to develop low-cost, high-performance, non-iridium catalysts and catalyst-coated membranes, thereby developing an insurance policy against future supply chain issues.
  • "We're very pleased to initiate this joint development agreement with H2U Technologies to discover and evaluate new electrocatalyst compositions," said Executive Officer, Director Dr. Hisataka Yakabe.
  • We're very pleased to work with Tokyo Gas to help them accelerate the delivery of green hydrogen to their customers."

Dow and X-energy Advance Efforts to Deploy First Advanced Small Modular Nuclear Reactor at Industrial Site Under DOE’s Advanced Reactor Demonstration Program

Retrieved on: 
Wednesday, March 1, 2023
Environment, Sustainability, Alternative Energy, Green Technology, Energy, Nuclear, DOW, Carbon, Dow Chemical Company, DuPont, Plastic, NRC, DOE, Terrorism, Annual report, Weather, Silicone, NYSE, Energy Independence and Security Act of 2007, Workforce, Engineering, COVID-19, Electricity, Growth, U.S. Department of Defense Strategy for Operating in Cyberspace, Intellectual property, Steam, JDA, TDCC, Failure, HTGR, Licensure, Risk, Uranium mining, Renewable energy, Fine chemical, Dow

The JDA work scope also includes the preparation and submission of a Construction Permit application to the U.S. Nuclear Regulatory Commission (“NRC”).

Key Points: 
  • The JDA work scope also includes the preparation and submission of a Construction Permit application to the U.S. Nuclear Regulatory Commission (“NRC”).
  • The parties intend to perform further ARDP-related work under the JDA as the project progresses.
  • “Today’s announcement demonstrates the commercial versatility of the Xe-100 and is an important milestone for the future of advanced nuclear and carbon-free energy around the world.
  • X-energy’s collaboration with Dow brings added significance because of the immense opportunity to further reduce emissions in the energy-intensive industrial sector,” said X-energy CEO J. Clay Sell.

TransCode Therapeutics and BRAIN Biotech join forces to develop a CRISPR-derived technology platform for cancer treatment

Retrieved on: 
Wednesday, February 22, 2023
Clinical trial, Therapy, Doctor of Philosophy, Cancer, Genomics, RNA interference, Partnership, BRAIN, Biomarker, TTX, Transcoding, CRISPR, JDA, Messenger, Neoplasm, RNA, Vaccine

The objective of the JDA is to co-develop a platform technology that combines a Class 2 CRISPR nuclease, the cell-killing G-dase E, developed by BRAIN Biotech's Akribion Genomics unit with TransCode's TTX nucleic acid delivery platform for the treatment of cancer.

Key Points: 
  • The objective of the JDA is to co-develop a platform technology that combines a Class 2 CRISPR nuclease, the cell-killing G-dase E, developed by BRAIN Biotech's Akribion Genomics unit with TransCode's TTX nucleic acid delivery platform for the treatment of cancer.
  • TransCode’s proprietary TTX platform is designed to enable systemic delivery of targeted nucleic acid-based therapeutics to tumors and metastases.
  • Combining these technologies could unlock the potential of CRISPR-like cell targeting approaches for the treatment of cancer.
  • This partnership with TransCode is therefore an important step on our challenging path to enter the field of cancer therapeutics with a new class of cancer treatment.”
    “Cell targeting technology based on genomic characteristics holds tremendous potential for the treatment of cancer.

EQS-News: BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment

Retrieved on: 
Wednesday, February 22, 2023
Biomarker, JDA, Therapy, Genomics, Transcoding, TTX, CRISPR, RNA, Partnership, BRAIN, Neoplasm, Cancer, Doctor of Philosophy, Vaccine

The objective of the JDA is to co-develop a platform technology that combines a Class 2 CRISPR nuclease, the cell-killing G-dase E, developed by BRAIN Biotech's Akribion Genomics unit with TransCode's TTX nucleic acid delivery platform for the treatment of cancer.

Key Points: 
  • The objective of the JDA is to co-develop a platform technology that combines a Class 2 CRISPR nuclease, the cell-killing G-dase E, developed by BRAIN Biotech's Akribion Genomics unit with TransCode's TTX nucleic acid delivery platform for the treatment of cancer.
  • TransCode’s proprietary TTX platform is designed to enable systemic delivery of targeted nucleic acid-based therapeutics to tumors and metastases.
  • This partnership with TransCode is therefore an important step on our challenging path to enter the field of cancer therapeutics with a new class of cancer treatment.
  • Zdravka Medarova, PhD, Co-founder and CTO of TransCode, comments: “Cell targeting technology based on genomic characteristics holds tremendous potential for the treatment of cancer.

Hess Reports Estimated Results for the Fourth Quarter of 2022

Retrieved on: 
Wednesday, January 25, 2023
Energy, Natural Resources, Other Natural Resources, Oil, Gas, Destiny, Public expenditure, Water, JDA, Hess Corporation, Hess, Corporation, Midstream, NGL, Carbon, Weather, Prosperity, GAAP, Fangtooth, Barrel, Liza, Sale, ONE, Interest, FPSO Noble Seillean, Uaru, Video game, Airline, Petroleum, Pharmaceutical industry, Gulf of Mexico, Yellowtail

E&P net income was $667 million in the fourth quarter of 2022, compared with $309 million in the fourth quarter of 2021.

Key Points: 
  • E&P net income was $667 million in the fourth quarter of 2022, compared with $309 million in the fourth quarter of 2021.
  • Net production, excluding Libya, was 376,000 boepd in the fourth quarter of 2022, compared with 295,000 boepd in the fourth quarter of 2021, primarily due to higher production in Guyana.
  • After-tax expense for Corporate, Interest and Other was $107 million in the fourth quarter of 2022, compared with $118 million in the fourth quarter of 2021.
  • Net cash provided by operating activities was $1,252 million in the fourth quarter of 2022, up from $899 million in the fourth quarter of 2021.

ThroughPut Inc. Appoints Award-winning Supply Chain and Operations Expert Steve Robinson to Advisory Board

Retrieved on: 
Thursday, February 9, 2023
Organization, Operational excellence, XPO, Inc., JDA, Roadway Express, Industrial, Marketing, Merchandising, Starbucks, Supply chain, SKU, Blue Yonder, Entrepreneurship, Army Network Enterprise Technology Command, Silicon, ToC, PALO, XPO, Fortune 500, Central Waqf Council, Chain, Product marketing, Blue, Iwill Campaign, UPS, Walmart, Learning, Network throughput, Supply, Advisory board, Retail

PALO ALTO, Calif., Feb. 9, 2023 /PRNewswire/ -- ThroughPut Inc., the Industrial AI Supply Chain pioneer, today announced the addition of Steve Robinson to its Board of Advisors. Steve is an award-winning supply chain and operations expert with over 20 years of experience heading multi-billion dollar global strategy, operations, and supply chain transformations for some of the world's largest, most complex organizations.

Key Points: 
  • Steve is an award-winning supply chain and operations expert with over 20 years of experience heading multi-billion dollar global strategy, operations, and supply chain transformations for some of the world's largest, most complex organizations.
  • ThroughPut's advanced AI and data-driven approach to solving modern businesses key supply and operational challenges is widely successful in delivering value across the entire supply chain spectrum, including end-to-end visibility into supply chain operations, predictive analysis of near-term supply chain disruptions, and actionable real-time recommendations to increase operational responsiveness.
  • "It's an honor to have Steve join our board to help scale our rapid supply chain intervention platform.
  • explained Ali Raza, CEO of ThroughPut Inc.
    "I am honored to have been welcomed into the fold of ThroughPut Inc.'s Advisory Board," said Steve Robinson.

ThroughPut Inc. Appoints Award-winning Supply Chain and Operations Expert Steve Robinson to Advisory Board

Retrieved on: 
Thursday, February 9, 2023
Organization, Operational excellence, XPO, Inc., JDA, Roadway Express, Industrial, Marketing, Merchandising, Starbucks, Supply chain, SKU, Blue Yonder, Entrepreneurship, Army Network Enterprise Technology Command, Silicon, ToC, PALO, XPO, Fortune 500, Central Waqf Council, Chain, Product marketing, Blue, Iwill Campaign, UPS, Walmart, Learning, Network throughput, Supply, Advisory board, Retail

PALO ALTO, Calif., Feb. 9, 2023 /PRNewswire/ -- ThroughPut Inc., the Industrial AI Supply Chain pioneer, today announced the addition of Steve Robinson to its Board of Advisors. Steve is an award-winning supply chain and operations expert with over 20 years of experience heading multi-billion dollar global strategy, operations, and supply chain transformations for some of the world's largest, most complex organizations.

Key Points: 
  • Steve is an award-winning supply chain and operations expert with over 20 years of experience heading multi-billion dollar global strategy, operations, and supply chain transformations for some of the world's largest, most complex organizations.
  • ThroughPut's advanced AI and data-driven approach to solving modern businesses key supply and operational challenges is widely successful in delivering value across the entire supply chain spectrum, including end-to-end visibility into supply chain operations, predictive analysis of near-term supply chain disruptions, and actionable real-time recommendations to increase operational responsiveness.
  • "It's an honor to have Steve join our board to help scale our rapid supply chain intervention platform.
  • explained Ali Raza, CEO of ThroughPut Inc.
    "I am honored to have been welcomed into the fold of ThroughPut Inc.'s Advisory Board," said Steve Robinson.

IDTechEx Discusses What to Expect From the Graphene Industry in 2023

Retrieved on: 
Friday, January 13, 2023
JDA, News, CES, EV, Blood, Nationwide, Membrane, EMI, Molybdenum disulfide, Publication, Graphene, 2D, Silicon, Great, Carbon, Radar, OCSiAl, Hope, Water, Policy, Polymer, Common-mode rejection ratio, Research, Filtration, Information economy, Zhurong (rover), GO, Eye, Investment, Success, Carbon fibers, MXenes

IDTechEx has provided the most comprehensive independent market report on graphene and other 2D materials for more than 10 years.

Key Points: 
  • IDTechEx has provided the most comprehensive independent market report on graphene and other 2D materials for more than 10 years.
  • 2023 will present a fascinating year for the graphene industry.
  • IDTechEx has for many years stated the inevitable consolidation of the graphene industry; just look at equivalent mature markets.
  • These successes will be good news for the industry, but IDTechEx do not expect them to be as large as many hope.

Carbios and Novozymes Strengthen Collaboration With Long-Term Exclusive Strategic Partnership to Secure Worldwide Leadership in Biorecycling of PET

Retrieved on: 
Thursday, January 12, 2023
Green Technology, Environmental Health, Environment, Recycling, Sustainability, JDA, Textile, PLA, Agriculture, Marketing, Environment, Partnership, Enzyme, Multimedia, Plastic, Management, Fine chemical, Carbios, Novozymes

Carbios and Novozymes have had a partnership since 2019 to develop enzyme-based solutions and address the sustainability challenge of plastic pollution, both within PET-recycling1 and PLA-biodegradation2.

Key Points: 
  • Carbios and Novozymes have had a partnership since 2019 to develop enzyme-based solutions and address the sustainability challenge of plastic pollution, both within PET-recycling1 and PLA-biodegradation2.
  • Building on the current Joint Development Agreement (JDA), under the new agreement, Carbios and Novozymes will extend their collaboration to develop, optimize and produce enzymes that will subsequently be supplied by Novozymes to all licensees of Carbios’ technology.
  • The strategic partnership supports the large-scale industrial deployment of Carbios’ patented PET-recycling technology starting with Carbios’ future industrial reference unit in Longlaville (France), which will be the world’s first biological PET-recycling plant.
  • “By providing biological solutions at a large scale, Novozymes is pleased to contribute in bringing Carbios’ biorecycling of PET-plastics and fibers to market.”